21 results
424B3
BBLNF
Babylon Holdings Ltd
17 Jun 22
Prospectus supplement
5:01pm
31,
Revenue
Clinical care delivery expense
Claims expense
Platform & application expenses
Research & development expenses
Sales, general … significant financial and other resources to our research and development efforts in order to continuously evolve the development of our products
F-4
BBLNF
Babylon Holdings Ltd
20 May 22
Registration of securities (foreign)
5:13pm
Claims expense
Platform & application expenses
Research & development expenses
Sales, general & administrative expenses
Recapitalization transaction … significant financial and other resources to our research and development efforts in order to continuously evolve the development of our products
424B3
BBLNF
Babylon Holdings Ltd
9 May 22
Prospectus supplement
4:15pm
and Loss
For the Years Ended December 31,
Revenue
Cost of care delivery
Platform & application expenses
Research & development expenses
Sales … , cost savings, revenues or other expected benefits. If we spend significant time and effort on research and development and are unable to generate
424B3
BBLNF
Babylon Holdings Ltd
3 May 22
Prospectus supplement
4:16pm
Cost of care delivery
Platform & application expenses
Research & development expenses
Sales, general & administrative expenses
Recapitalization … of operations.
We expect to continue to dedicate significant financial and other resources to our research and development efforts in order to continuously
F-1
BBLNF
Babylon Holdings Ltd
29 Apr 22
Registration statement (foreign)
5:09pm
For the Years Ended December 31,
$’000
Revenue
Cost of care delivery
Platform & application expenses
Research & development expenses
Sales, general … financial and other resources to our research and development efforts in order to continuously evolve the development of our products and maintain
POS AM
zotfc03jzf
28 Apr 22
Prospectus update (post-effective amendment)
5:28pm
424B3
d9en9gd9 vb0efa89
30 Mar 22
Prospectus supplement
5:19pm
20-F
qcldt1w50lak03
30 Mar 22
Annual report (foreign)
4:12pm
424B4
x3hcv7f y38y812sm8v
30 Nov 21
Prospectus supplement with pricing info
5:27pm
6-K
EX-99.1
u83qfk
12 Nov 21
Babylon Delivers Strong Third Quarter 2021 Operational and Financial Results
6:14am
F-1
81gskxx
9 Nov 21
Registration statement (foreign)
12:00am
424B3
b2rvni
30 Sep 21
Prospectus supplement
4:54pm
F-4/A
nilo9l8fyyb3s
27 Sep 21
Registration of securities (foreign) (amended)
10:48am
F-4/A
lcyus6
15 Sep 21
Registration of securities (foreign) (amended)
8:34am
CORRESP
k58cdsgjhi
15 Sep 21
Correspondence with SEC
12:00am
UPLOAD
28uhz6 zl
8 Sep 21
Letter from SEC
12:00am
F-4/A
w2a1uz8wh6z uq0d
24 Aug 21
Registration of securities (foreign) (amended)
4:08pm
CORRESP
6cscno
24 Aug 21
Correspondence with SEC
12:00am
UPLOAD
nvl4sny70refh8rkt
18 Aug 21
Letter from SEC
12:00am
F-4/A
asw4ygs0wwru
9 Aug 21
Registration of securities (foreign) (amended)
12:00am